Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,004 | 2,306 | 3,449 | 253 | 747 |
| Marketable Securities | N/A | 7 | 4,700 | 2,800 | 4,500 |
| Receivables | 629 | 404 | 419 | 228 | 244 |
| Inventories | 653 | 724 | 336 | 512 | 815 |
| TOTAL | $2,421 | $3,603 | $9,296 | $4,233 | $6,664 |
| Non-Current Assets | |||||
| PPE Net | 210 | 412 | 762 | 911 | 1,143 |
| Other Non-Current Assets | 21 | 21 | 27 | 23 | 18 |
| TOTAL | $231 | $433 | $789 | $934 | $1,161 |
| Total Assets | $2,652 | $4,036 | $10,085 | $5,167 | $7,825 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 455 | 986 | 488 | 568 | 766 |
| Accrued Expenses | 239 | 516 | 841 | 744 | 769 |
| TOTAL | $694 | $1,502 | $1,329 | $1,692 | $1,831 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 184 | 614 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 5,388 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $5,572 | $614 |
| Total Liabilities | $694 | $1,502 | $1,329 | $7,264 | $2,445 |
| Shareholders' Equity | |||||
| Common Shares | 42 | 38 | 38 | 12 | 12 |
| Retained earnings | -89,975 | -87,949 | -81,612 | -55,256 | -47,243 |
| Other shareholders' equity | 76 | 70 | 110 | 12 | -2,239 |
| TOTAL | $1,958 | $2,534 | $8,756 | $-2,097 | $5,380 |
| Total Liabilities And Equity | $2,652 | $4,036 | $10,085 | $5,167 | $7,825 |